What ORAMED PHARMACEUTICALS INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 2 | 4 |
| Total trades | 25 | 56 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 5,043,135 | 7,082,891 |
| Disposed | 50,000 | 926,428 |
| Net activity | +4,993,135 | +6,156,463 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Shapiro Benjamin | Director | Nov 12 | Grant / award · A | +1,050 | — | — | 197,050 |
| Shapiro Benjamin | Director | Nov 12 | Grant / award · A | +72,780 | — | — | 196,000 |
| Mayer Arie | Director | Nov 12 | Grant / award · A | +1,470 | — | — | 242,259 |
| Mayer Arie | Director | Nov 12 | Grant / award · A | +72,780 | — | — | 240,789 |
| Reznick Yehuda | Director | Nov 12 | Grant / award · A | +2,890 | — | — | 180,850 |
| Reznick Yehuda | Director | Nov 12 | Grant / award · A | +72,780 | — | — | 177,960 |
| Hexter Joshua | COO & CBO | Nov 12 | Grant / award · A | +242,000 | — | — | 1,927,130 |
| Hexter Joshua | COO & CBO | Nov 12 | Grant / award · A | +357,000 | — | — | 1,685,130 |
| Gabay Avraham | Chief Financial Officer | Nov 12 | Grant / award · A | +242,000 | — | — | 1,460,076 |
| Gabay Avraham | Chief Financial Officer | Nov 12 | Grant / award · A | +357,000 | — | — | 1,218,076 |
| Kidron Nadav | President and CEO | Nov 12 | Grant / award · A | +688,000 | — | — | 5,457,505 |
| Kidron Nadav | President and CEO | Nov 12 | Grant / award · A | +629,000 | — | — | 4,769,505 |
| Aghion Daniel | Director | Nov 12 | Grant / award · A | +2,890 | — | — | 189,111 |
| Aghion Daniel | Director | Nov 12 | Grant / award · A | +72,780 | — | — | 186,221 |
| Kidron Miriam | Chief Scientific Officer | Nov 12 | Grant / award · A | +242,000 | — | — | 2,149,554 |
| Kidron Miriam | Chief Scientific Officer | Nov 12 | Grant / award · A | +357,000 | — | — | 1,907,554 |
| Gabay Avraham | Chief Financial Officer | Oct 01 | Disclosed 10b5-1 sale · S | −20,000 | $4.51 | −$90.2K | 861,076 |
| Hexter Joshua | COO & CBO | Oct 01 | Disclosed 10b5-1 sale · S | −30,000 | $4.51 | −$135K | 1,328,130 |
| Kidron Miriam | Chief Scientific Officer | Sep 24 | Grant / award · A | +209,291 | — | — | 1,550,554 |
| Kidron Miriam | Chief Scientific Officer | Sep 24 | Grant / award · A | +208,125 | — | — | 1,341,263 |
Loading...